SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations
9 references·7 citing·42 second hop
Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations (2013)Adverse event assessment, analysis, and r…Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: An ACTTION systematic review (2012)Adherence to CONSORT harms-re…The quality of safety reporting in trials is still suboptimal: Survey of major general medical journals (2010)The quality of safety reporti…Reporting of Safety Results in Published Reports of Randomized Controlled Trials (2009)Reporting of Safety Results i…Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials (2009)Differences in Adverse Effect…Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement (2004)Better Reporting of Harms in …Core outcome domains for chronic pain clinical trials: IMMPACT recommendations (2003)Core outcome domains for chro…Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas. (2001)Completeness of safety report…Reporting of Adverse Effects in Clinical Trials Should Be Improved (1999)Reporting of Adverse Effects …Reporting of safety data from randomised trials (1998)Reporting of safety data from…Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Medical Cannabis and Cannabis-based Medicines for Chronic Noncancer Pain (2020)Adherence to Consolidated Sta…Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) (2019)Recommendations for the Repor…Checklist for the preparation and review of pain clinical trial publications: a pain-specific supplement to CONSORT (2017)Checklist for the preparation…Adverse Event Reporting in Clinical Trials of Intravenous and Invasive Pain Treatments: An ACTTION Systematic Review (2016)Adverse Event Reporting in Cl…Assessment of the quality of harms reporting in non-randomised studies and randomised controlled studies of topiramate for the treatment of epilepsy using CONSORT criteria (2015)Assessment of the quality of …Adverse event methods were heterogeneous and insufficiently reported in randomized trials on persistent depressive disorder (2015)Adverse event methods were he…Adverse event reporting in nonpharmacologic, noninterventional pain clinical trials: ACTTION systematic review (2014)Adverse event reporting in no…Empirical Evidence of Bias (1995)Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials (1995)Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996)Reporting of adverse drug reactions in randomised controlled trials – a systematic survey (2001)Challenges in Systematic Reviews That Assess Treatment Harms (2005)Adherence to CONSORT Adverse Event Reporting Guidelines in Randomized Clinical Trials Evaluating Systemic Cancer Therapy: A Systematic Review (2013)Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study (1997)Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010 (2013)Effectiveness of metacognitive interventions for mental disorders in adults—A systematic review and meta‐analysis (METACOG) (2018)Assessing the unwanted: A systematic review of instruments used to assess negative effects of psychotherapy (2019)Strengthening the reporting of harms of all interventions in clinical trials (2022)Reporting results of cancer treatment (1981)The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials (2001)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement (2007)CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010)Cumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction (1992)Improving the quality of reporting of randomized controlled trials. The CONSORT statement (1996)Meta-Analysis, Decision Analysis, and Cost-Effectiveness Analysis (1999)Reporting bias in medical research - a narrative review (2010)PRISMA harms checklist: improving harms reporting in systematic reviews (2016)Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions (2017)An Inventory for Measuring Depression (1961)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2001)Acceptance-based interventions for the treatment of chronic pain: A systematic review and meta-analysis (2011)Developing core outcome sets for clinical trials: issues to consider (2012)The COMET Handbook: version 1.0 (2017)CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010)CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials (2010)Assessing the quality of randomized controlled trials: An annotated bibliography of scales and checklists (1995)Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond (2004)Safety Reporting in Randomized Trials of Mental Health Interventions (2004)Experimenter Effects in Behavioral Research (1968)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)Reporting of harms in randomized controlled trials of psychological interventions for mental and behavioral disorders: A review of current practice (2014)Tripping on nothing: placebo psychedelics and contextual factors (2020)Poor adherence of randomised trials in surgery to CONSORT guidelines for non-pharmacological treatments (NPT): a cross-sectional study (2013)Reporting of Adverse Events in Published and Unpublished Studies of Health Care Interventions: A Systematic Review (2016)Preferred reporting items for overviews of systematic reviews including harms checklist: a pilot tool to be used for balanced reporting of benefits and harms (2017)CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials (2023)
this work references cited by second hop

References

  • 2003Core outcome domains for chronic pain clinical trials: IMMPACT recommendations3,496 cited
  • 2004Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement1,588 cited
  • 2001Completeness of safety reporting in randomized trials: an evaluation of 7 medical areas.564 cited
  • 2009Reporting of Safety Results in Published Reports of Randomized Controlled Trials285 cited
  • 2009Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials202 cited
  • 1999Reporting of Adverse Effects in Clinical Trials Should Be Improved167 cited
  • 1998Reporting of safety data from randomised trials97 cited
  • 2010The quality of safety reporting in trials is still suboptimal: Survey of major general medical journals84 cited
  • 2012Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: An ACTTION systematic review65 cited

Cited by

  • 2015Adverse event methods were heterogeneous and insufficiently reported in randomized trials on persistent depressive disorder45 cited
  • 2017Checklist for the preparation and review of pain clinical trial publications: a pain-specific supplement to CONSORT45 cited
  • 2014Adverse event reporting in nonpharmacologic, noninterventional pain clinical trials: ACTTION systematic review27 cited
  • 2019Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

20 cited
  • 2016Adverse Event Reporting in Clinical Trials of Intravenous and Invasive Pain Treatments: An ACTTION Systematic Review19 cited
  • 2015Assessment of the quality of harms reporting in non-randomised studies and randomised controlled studies of topiramate for the treatment of epilepsy using CONSORT criteria15 cited
  • 2020Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Medical Cannabis and Cannabis-based Medicines for Chronic Noncancer Pain14 cited